This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Determination of Safety and Efficacy of a Laser With Cooling for Treatment of Skin

This study has been completed.
Information provided by (Responsible Party):
Candela Corporation Identifier:
First received: May 9, 2006
Last updated: August 2, 2012
Last verified: August 2012
The appearance of aged skin is a common cosmetic complaint of middle aged and older individuals. This study evaluates the safety and efficacy of a new laser with cooling to improve the appearance of aged skin. The laser being used will heat various depths of the skin while protecting the outer layer.

Condition Intervention
Aged Skin Device: dermatological infrared laser

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science

Resource links provided by NLM:

Further study details as provided by Candela Corporation:

Primary Outcome Measures:
  • score on a grading scale at post treatment visits

Enrollment: 36
Study Start Date: August 2005
Study Completion Date: January 2007
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   30 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes


Aged skin, light to medium skin types.


Known photosensitivity Any of the following pre-existing skin conditions: eczema, psoriasis, allergic dermatitis or other conditions that may affect treatment.

Other treatments within the past year for aged facial skin

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00323921

Sponsors and Collaborators
Candela Corporation
Principal Investigator: E. V. Ross, M.D. United States Naval Medical Center, San Diego
  More Information

Responsible Party: Candela Corporation Identifier: NCT00323921     History of Changes
Other Study ID Numbers: 052603
Study First Received: May 9, 2006
Last Updated: August 2, 2012

Additional relevant MeSH terms:
Dermatologic Agents processed this record on August 22, 2017